Product NDC: | 49884-397 |
Proprietary Name: | Omeprazole and Sodium Bicarbonate |
Non Proprietary Name: | Omeprazole and Sodium Bicarbonate |
Active Ingredient(s): | 20; 1100 mg/1; mg/1 & nbsp; Omeprazole and Sodium Bicarbonate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-397 |
Labeler Name: | Par Pharmaceutical Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078966 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100701 |
Package NDC: | 49884-397-11 |
Package Description: | 30 CAPSULE in 1 BOTTLE (49884-397-11) |
NDC Code | 49884-397-11 |
Proprietary Name | Omeprazole and Sodium Bicarbonate |
Package Description | 30 CAPSULE in 1 BOTTLE (49884-397-11) |
Product NDC | 49884-397 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Omeprazole and Sodium Bicarbonate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20100701 |
Marketing Category Name | ANDA |
Labeler Name | Par Pharmaceutical Inc. |
Substance Name | OMEPRAZOLE; SODIUM BICARBONATE |
Strength Number | 20; 1100 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |